June 12, 2018 - Assignment

Nordic Capital divests AniCura to Mars Petcare

Nordic Capital Fund VIII has agreed to divest AniCura, one of Europe’s leading providers of high quality veterinary care for companion animals to Mars Petcare, a diverse and growing pet health and nutrition business. The parties have agreed not to disclose financial details. The transaction is subject to customary regulatory approvals.

Since becoming the majority owner just four years ago, Nordic Capital and AniCura’s management team have succeeded in shaping the European vet care landscape by creating a specialised clinic business with high quality pet care. AniCura has grown fourfold since Nordic Capital’s acquisition in 2014. It has increased its number of clinics from 50 to 200, its employees from 1,000 to 4,000 and its pro forma revenues have grown from SEK 0.9 bn to SEK 3.3 bn.

Nordic Capital is represented by Mannheimer Swartling in the transaction.